Drug Shortage Report for MYLAN-GLICLAZIDE MR
| Report ID | 243790 |
| Drug Identification Number | 02438658 |
| Brand name | MYLAN-GLICLAZIDE MR |
| Common or Proper name | GLICLAZIDE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLICLAZIDE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | A10BB |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-11-29 |
| Actual start date | |
| Estimated end date | 2025-02-25 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-11-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-11-30 | English | Compare |
| v2 | 2024-11-25 | French | Compare |
| v1 | 2024-11-25 | English | Compare |
Showing 1 to 3 of 3